In This Section

Spotlight on Clinical Trials

The abstract submission portal is closed for clinical trial abstract submissions. No more abstracts can be accepted for consideration for presentation at the Annual Meeting.

Key Dates: Abstract Status Notification and Embargo Release

  • February 13, 2025: Abstract Submission Site Re-Opens for Submission of Final Clinical Trial Placeholder Abstracts
    (Authors of Placeholder Abstracts will be notified via email when the Submitter is open)
  • February 18, 2025: Final Results and Conclusions Due for Clinical Trial Placeholder Abstracts (5 p.m. ET)
  • February 25, 2025: Status Notifications and Scheduling Information Sent for Clinical Trials Abstracts (submitted for January 16 deadline)
  • March 25, 2025: Titles of Clinical Trial Abstracts Posted to Online Itinerary Planner (4:30 p.m. ET)
  • April 25, 2024: Text of Clinical Trial Abstracts Posted to Online Itinerary Planner (12 p.m. CT)

Clinical Trial Presentation Opportunities

  • Numerous and unique oral presentation opportunities, including:
    • Four Clinical Trials Plenary Sessions offering companion presentations discussing the science behind the trials presented
    • Three Clinical Trials Minisymposia
  • Poster presentations
  • Opportunities for extensive national media coverage through the AACR press program
  • Opportunities to publish a manuscript in one of the AACR’s highly regarded journals, including possible simultaneous publication with your abstract presentation
    • Review the FAQ relating to simultaneous publication in the AACR Journals for more information
    • Contact [email protected] with any questions
  • No restrictions on presenters for poster presentations if the presentation is CME-compliant. Owners or employees of ineligible companies are not eligible to participate as a speaker if the work is selected for an oral presentation. Visit the CME page for more information.

EMBARGO POLICY AND ONLINE PUBLICATION OF ABSTRACTS

  • In accordance with the AACR’s embargo policy, the content of abstracts must be kept confidential until they are made publicly available:  
  • The titles and authors of the Clinical Trial and Late-Breaking Abstracts will be posted to the AACR Online Itinerary Planner no earlier than 4:30 p.m. U.S. ET on Tuesday, March 25, 2025. (Abstract Texts are Embargoed until 12:00 p.m. U.S. ET on Friday, April 25, 2025) 
  • The full text of the Clinical Trial and Late-Breaking Abstracts will be posted to the AACR Online Itinerary Planner and the Meeting App no earlier than 12:00 p.m. U.S. PT on Friday, April 25, 2025, except those abstracts that are selected for inclusion in the official AACR press program. Abstracts that are featured in the official AACR press program will be made publicly available at the date and time of presentation, either at the meeting or an official AACR press conference.  
  • In previous years, abstracts accepted for presentation at the AACR Annual Meeting were published in an online-only Proceedings supplement to the AACR journal Cancer Research after the conclusion of the meeting. For the AACR Annual Meeting 2025, the Proceedings supplement will be published prior to the meeting in two parts. Part 1 of the online Proceedings (regular abstracts) will be published on Friday, March 22, and Part 2 (clinical trials and late-breaking abstracts) will be published on Friday, April 25. Revised Proceedings supplements containing the full text of embargoed abstracts as well as any late change will be published in Cancer Research approximately one month after the meeting.